Handle With Care: Clarivate Plc (NYSE: CLVT)

Currently, there are 666.10M common shares owned by the public and among those 369.32M shares have been available to trade.

The company’s stock has a 5-day price change of 3.47% and -19.44% over the past three months. CLVT shares are trading -19.44% year to date (YTD), with the 12-month market performance down to -19.53% lower. It has a 12-month low price of $6.07 and touched a high of $10.03 over the same period. CLVT has an average intraday trading volume of 4.05 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.63%, -8.87%, and -6.38% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Clarivate Plc (NYSE: CLVT) shares accounts for 64.60% of the company’s 666.10M shares outstanding.

It has a market capitalization of $4.97B and a beta (3y monthly) value of 1.24. The earnings-per-share (ttm) stands at -$1.48. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.72% over the week and 3.01% over the month.

Analysts forecast that Clarivate Plc (CLVT) will achieve an EPS of $0.14 for the current quarter, $0.19 for the next quarter and $0.81 for 2025. The lowest estimate earnings-per-share for the quarter is $0.13 while analysts give the company a high EPS estimate of $0.15. Comparatively, EPS for the current quarter was $0.18 a year ago. Earnings per share for the fiscal year are expected to decrease by -8.30%, and 7.18% over the next financial year. EPS should shrink at an annualized rate of 4.70% over the next five years, compared to 60.20% over the past 5-year period.

Looking at the support for the CLVT, a number of firms have released research notes about the stock. Wells Fargo stated their Underweight rating for the stock in a research note on December 15, 2023, with the firm’s price target at $8. Jefferies coverage for the Clarivate Plc (CLVT) stock in a research note released on October 16, 2023 offered a Buy rating with a price target of $8.50. Barclays was of a view on September 08, 2023 that the stock is Underweight, while RBC Capital Mkts gave the stock Sector Perform rating on August 25, 2023, issuing a price target of $9- $8. BofA Securities on their part issued Underperform rating on August 07, 2023.

Most Popular

Related Posts